The perils with the misuse of predictive power

Pharmaceutical Statistics

Volumn 10, Issue 4, 2011, Pages 311-317

  Dallow, Nigel ^a   Fina, Paolo ^b  

^a GLAXOSMITHKLINE   (United Kingdom)

^b Aptuit Inc   (United States)

Author keywords

conditional power; interim analysis; predictive power

Indexed keywords

ARTICLE; CALCULATION; DECISION MAKING; DRUG INDUSTRY; HUMAN; NOSE POLYP; PREDICTIVE VALUE; SAMPLE SIZE; STATISTICAL ANALYSIS; UNCERTAINTY;

CLINICAL TRIALS AS TOPIC; DATA INTERPRETATION, STATISTICAL; DECISION MAKING; DRUG DESIGN; ENDPOINT DETERMINATION; HUMANS; MODELS, STATISTICAL; SAMPLE SIZE;

EID: 79960802141     PISSN: 15391604     EISSN: 15391612     Source Type: Journal    
DOI: 10.1002/pst.467     Document Type: Article

References (11)

1. ICH E9 Expert Working Group. Statistical principles for clinical trials: ICH harmonised tripartite guideline. Statistics in Medicine 1999; 18: 1905-1942.
2. Wang M-D,. Sample size reestimation by Bayesian prediction. Biometrical Journal 2007; 49:3; 365-377
3. Dmitrienko A, Wang D-M,. Bayesian predictive approach to interim monitoring in clinical trials. Statistics in Medicine 2006; 25: 2178-2195; DOI: 10.1002/sim.2204. (Pubitemid 43985453)
4. Spiegelhalter DJ, Freedman LS, Blackburn PR,. Monitoring clinical trials: conditional or predictive power? Controlled Clinical Trials 1986; 7: 8-17; DOI: 10.1016/0197-2456(86)90003-6. (Pubitemid 16166393)
5. Proschan MA, Lan KK, Wittes JT,. Statistical monitoring of clinical trials, a unified approach. Springer: Berlin, 2006; DOI: 10.1081/BIP-100101198.
6. Jennison C, Turnbull B,. Group sequential methods with applications to clinical trials. Chapman & Hall: London, 2000.
7. Snapinn S, Chen M-G, Jiang Q, Koutsoukos T,. Assessment of futility in clinical trials. Pharmaceutical Statistics 2006; 5: 273-281; DOI: 10.1002/pst.216. (Pubitemid 46023756)
8. Grouin JM, Coste M, Bunouf P, Lecoutre B,. Bayesian sample size determination in non-sequential clinical trials: statistical aspects and some regulatory considerations. Statistics in Medicine 2007; 26: 4914-4924; DOI: 10.1002/sim.2958. (Pubitemid 350064913)
9. Spiegelhalter DJ, Abrams KR, Myles JP,. Bayesian approaches to clinical trial and health-care evaluation. Wiley: New York, 2004; DOI: 10.1002/0470092602.
10. O'Hagan A, Stevens JW, Campbell MJ,. Assurance in clinical trial design. Wiley: New York, 2005; DOI: 10.1002/pst.175. (Pubitemid 41358690)
11. Chuang-Stein C,. Sample size and the probability of a successful trial. Wiley: New York, 2006; DOI: 10.1002/pst.232 (Pubitemid 46023759)